196
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Preeclampsia – a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia

, , , , , , & show all

References

  • Raisz LG. Physiology and pathophysiology of bone remodeling. Clin Chem 1999;45:1353–8
  • Pitkin RM. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 1985;151:99–109
  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
  • Anim-Nyame N, Sooranna SR, Jones J, et al. Biochemical markers of maternal bone turnover are elevated in pre-eclampsia. BJOG 2001;108:258–62
  • Anim-Nyame N, Sooranna SR, Jones J, et al. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. BJOG 2002;109:708–13
  • Kumtepe Y, Aksoy H, Ingec M. Bone turnover in preeclamptic and normotensive pregnancy. Int J Gynaecol Obstet 2005;88:323–4
  • Kumar A, Devi SG, Prasad S, et al. Bone turnover in preeclampsia-complicated pregnancy in North Indian women. J Obstet Gynaecol Res 2012;38:172–9
  • Gorzelak M, Darmochwal-Kolarz D, Jablonski M, et al. The concentrations of osteocalcin and degradation products of type I collagen in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2001;98:23–7
  • Dorota DK, Bogdan KG, Mieczyslaw G, et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy 2012;31:166–76
  • Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL. Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 2010;87:99–107
  • Silverman SL. Sclerostin. J Osteoporos 2010;2010:941419
  • Li X, Zhang Y, Kang H, et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005;280:19883–7
  • Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005;280:26770–5
  • Ellies DL, Viviano B, McCarthy J, et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 2006;21:1738–49
  • Baron R, Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007;148:2635–43
  • Kubota T, Michigami T, Ozono K. Wnt signaling in bone metabolism. J Bone Miner Metab 2009;27:265–71
  • ACOG. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159–67
  • Shaarawy M, Zaki S, Ramzi AM, et al. Feto-maternal bone remodeling in normal pregnancy and preeclampsia. J Soc Gynecol Investig 2005;12:343–8
  • To WW, Wong MW. Bone mineral density changes in pregnancies with gestational hypertension: a longitudinal study using quantitative ultrasound measurements. Arch Gynecol Obstet 2011;284:39–44
  • Sowers M, Scholl T, Grewal J, et al. IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrinol Metab 2001;86:5898–903
  • Godang K, Froslie KF, Henriksen T, et al. Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates. Eur J Endocrinol 2013;168:371–8
  • Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 2011;26:2812–22
  • Modder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 2011;26:373–9
  • Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 2010;95:1991–7
  • Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 2010;95:2248–53
  • Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 2012;97:148–54
  • Ardawi MS, Rouzi AA, Qari MH. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 2012;97:3691–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.